Approval · Notice of Compliance 21509 · 2018
MATULANE: Notice of Compliance 21509
Issued November 8, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21509
- Date
- November 8, 2018
- Company
- Leadiant Biosciences, Inc.Scarborough, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To notify a change in the capsule shell composition
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MATULANE | Not yet assigned | — |
Medicinal ingredients
- PROCARBAZINE HCL 50 MG per CAP